Thrombophilic state in breast cancer

Keyphrases

• Breast Cancer 100%
• Cancer Patients 100%
• In Cancer 100%
• Thrombophilic 100%
• Thrombosis 60%
• Malignancy 40%
• Physiologic 40%
• Primary Breast Cancer 40%
• Selective Estrogen Receptor Modulators 40%
• Hormone Therapy 40%
• Thromboembolic Risk 20%
• Thrombus 20%
• Anticancer Drugs 20%
• Tumor Cells 20%
• Patient Benefit 20%
• Steroidal 20%
• Tumor Metastasis 20%
• Preventive Treatment 20%
• Adjuvant Therapy 20%
• Associated Risk 20%
• Metastatic Breast Cancer 20%
• Predisposing Factors 20%
• Comorbid 20%
• Mononuclear Cells 20%
• Cancer Prevention 20%
• Cause of Death 20%
• Hypercoagulable State 20%
• Hormone Replacement Therapy 20%
• Anticoagulation 20%
• Advanced Breast Cancer 20%
• Palliation 20%
• Drug Use 20%
• Blood Clot 20%
• Palliative Cancer Care 20%
• Blood Clotting Factors 20%
• Thromboembolism 20%
• Osteoporosis Treatment 20%
• Bed Rest 20%
• Fibrin Formation 20%
• Prothrombin Activation 20%
• Fibrin Generation 20%
• Clotting System 20%
• Indwelling Central Venous Catheter 20%
• Thrombosis Risk 20%
• Chemotoxic 20%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Breast Cancer 100%
• Thrombosis 80%
• Cancer 40%
• Tumor Cell 40%
• Hormone Therapy 40%
• Antithrombotic 40%
• Thromboembolism 40%
• Selective Estrogen Receptor Modulator 40%
• Disease Predisposition 20%
• Infection 20%
• Metastatic Carcinoma 20%
• Thrombus 20%
• Cancer Therapy 20%
• Blood Clotting 20%
• Cancer Prevention 20%
• Osteoporosis 20%
• Symptomatic Treatment 20%
• Metastatic Breast Cancer 20%
• Blood Clotting Factor 20%
• Mononuclear Cell 20%
• Procoagulant 20%
• Hormone Substitution 20%
• Anticarcinogen 20%
• Anticoagulation 20%
• Prothrombin 20%
• Fibrin Formation 20%
• Adjuvant Therapy 20%
• Bed Rest 20%
• Central Venous Catheter 20%